BMO Capital Markets Upgrade Canopy Growth Rating

Browse By

Canopy Growth Corp. (NYSE: CGC, TSX: WEED) was upgraded by BMO Capital Markets from a market perform rating to an outperform rating in a research note published by Benzinga reports on January 28th, 2020. BMO Capital Markets currently have set $40.00 price target Canopy Growth’s stock.

Recent News Regarding Beverage Launch Timeline

Canopy Growth reported on January 17, 2020 that the management remains very confident in the underlying beverage science and in Canopy’s ability to scale production and deliver high quality, differentiated cannabis beverages to the market. However, the scaling process is not complete, and Canopy Growth Corporation is extending its to-market date while the internal teams complete the final steps. See more below

This image has an empty alt attribute; its file name is cgc-open-graph-image.jpg

About Canopy Growth Corporation

Canopy Growth (TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth’s subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. Canopy Growth has operations in over a dozen countries across five continents.

Canopy Growth’s medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics.

Canopy Growth operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships.

From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates eleven licensed cannabis production sites with over 10.5 million square feet of production capacity, including over one million square feet of GMP certified production space. For more information visit www.canopygrowth.com

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.